184 related articles for article (PubMed ID: 35918045)
41. Glutamatergic transmission and receptor expression in the synucleinopathy h-α-synL62 mouse model: Effects of hydromethylthionine.
Schwab K; Chasapopoulou Z; Frahm S; Magbagbeolu M; Cranston A; Harrington CR; Wischik CM; Theuring F; Riedel G
Cell Signal; 2022 Sep; 97():110386. PubMed ID: 35709886
[TBL] [Abstract][Full Text] [Related]
42. Rab7 reduces α-synuclein toxicity in rats and primary neurons.
Szegö EM; Van den Haute C; Höfs L; Baekelandt V; Van der Perren A; Falkenburger BH
Exp Neurol; 2022 Jan; 347():113900. PubMed ID: 34695425
[TBL] [Abstract][Full Text] [Related]
43. The Stimulatory Effects of Intracellular α-Synuclein on Synaptic Transmission Are Attenuated by 2-Octahydroisoquinolin-2(1H)-ylethanamine.
Ramirez AE; Fernández-Pérez EJ; Olivos N; Burgos CF; Boopathi S; Armijo-Weingart L; Pacheco CR; González W; Aguayo LG
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948050
[TBL] [Abstract][Full Text] [Related]
44. The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson's disease.
Yasuda T; Mochizuki H
Apoptosis; 2010 Nov; 15(11):1312-21. PubMed ID: 20221696
[TBL] [Abstract][Full Text] [Related]
45. Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson's disease.
Faustini G; Longhena F; Varanita T; Bubacco L; Pizzi M; Missale C; Benfenati F; Björklund A; Spano P; Bellucci A
Acta Neuropathol; 2018 Oct; 136(4):621-639. PubMed ID: 30046897
[TBL] [Abstract][Full Text] [Related]
46. Human myeloperoxidase (hMPO) is expressed in neurons in the substantia nigra in Parkinson's disease and in the hMPO-α-synuclein-A53T mouse model, correlating with increased nitration and aggregation of α-synuclein and exacerbation of motor impairment.
Maki RA; Holzer M; Motamedchaboki K; Malle E; Masliah E; Marsche G; Reynolds WF
Free Radic Biol Med; 2019 Sep; 141():115-140. PubMed ID: 31175983
[TBL] [Abstract][Full Text] [Related]
47. Downregulation of α-Synuclein Protein Levels by an Intracellular Single-Chain Antibody.
Chen YH; Yu SJ; Wu KJ; Wang YS; Tsai HM; Liao LW; Chen S; Hsieh W; Chen H; Hsu SC; Chen ML; Hoffer BJ; Wang Y
J Parkinsons Dis; 2020; 10(2):573-590. PubMed ID: 32176654
[TBL] [Abstract][Full Text] [Related]
48. Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha -synuclein in human and transgenic mouse brain.
Kahle PJ; Neumann M; Ozmen L; Muller V; Jacobsen H; Schindzielorz A; Okochi M; Leimer U; van Der Putten H; Probst A; Kremmer E; Kretzschmar HA; Haass C
J Neurosci; 2000 Sep; 20(17):6365-73. PubMed ID: 10964942
[TBL] [Abstract][Full Text] [Related]
49. The Alpha-Synuclein RT-QuIC Products Generated by the Olfactory Mucosa of Patients with Parkinson's Disease and Multiple System Atrophy Induce Inflammatory Responses in SH-SY5Y Cells.
De Luca CMG; Consonni A; Cazzaniga FA; Bistaffa E; Bufano G; Quitarrini G; Celauro L; Legname G; Eleopra R; Baggi F; Giaccone G; Moda F
Cells; 2021 Dec; 11(1):. PubMed ID: 35011649
[TBL] [Abstract][Full Text] [Related]
50. Polypeptides derived from α-Synuclein binding partners to prevent α-Synuclein fibrils interaction with and take-up by cells.
Monsellier E; Bendifallah M; Redeker V; Melki R
PLoS One; 2020; 15(8):e0237328. PubMed ID: 32790707
[TBL] [Abstract][Full Text] [Related]
51. Presynaptic congenital myasthenic syndrome with altered synaptic vesicle homeostasis linked to compound heterozygous sequence variants in RPH3A.
Maselli RA; Vázquez J; Schrumpf L; Arredondo J; Lara M; Strober JB; Pytel P; Wollmann RL; Ferns M
Mol Genet Genomic Med; 2018 May; 6(3):434-440. PubMed ID: 29441694
[TBL] [Abstract][Full Text] [Related]
52. Intrastriatal injection of α-synuclein can lead to widespread synucleinopathy independent of neuroanatomic connectivity.
Sorrentino ZA; Brooks MMT; Hudson V; Rutherford NJ; Golde TE; Giasson BI; Chakrabarty P
Mol Neurodegener; 2017 May; 12(1):40. PubMed ID: 28552073
[TBL] [Abstract][Full Text] [Related]
53. VPS35 dysfunction impairs lysosomal degradation of α-synuclein and exacerbates neurotoxicity in a Drosophila model of Parkinson's disease.
Miura E; Hasegawa T; Konno M; Suzuki M; Sugeno N; Fujikake N; Geisler S; Tabuchi M; Oshima R; Kikuchi A; Baba T; Wada K; Nagai Y; Takeda A; Aoki M
Neurobiol Dis; 2014 Nov; 71():1-13. PubMed ID: 25107340
[TBL] [Abstract][Full Text] [Related]
54. Effects of Alpha-Synuclein Targeted Antisense Oligonucleotides on Lewy Body-Like Pathology and Behavioral Disturbances Induced by Injections of Pre-Formed Fibrils in the Mouse Motor Cortex.
Boutros SW; Raber J; Unni VK
J Parkinsons Dis; 2021; 11(3):1091-1115. PubMed ID: 34057097
[TBL] [Abstract][Full Text] [Related]
55. Accumulation of α-synuclein triggered by presynaptic dysfunction.
Nakata Y; Yasuda T; Fukaya M; Yamamori S; Itakura M; Nihira T; Hayakawa H; Kawanami A; Kataoka M; Nagai M; Sakagami H; Takahashi M; Mizuno Y; Mochizuki H
J Neurosci; 2012 Nov; 32(48):17186-96. PubMed ID: 23197711
[TBL] [Abstract][Full Text] [Related]
56. C-Terminal Tyrosine Residue Modifications Modulate the Protective Phosphorylation of Serine 129 of α-Synuclein in a Yeast Model of Parkinson's Disease.
Kleinknecht A; Popova B; Lázaro DF; Pinho R; Valerius O; Outeiro TF; Braus GH
PLoS Genet; 2016 Jun; 12(6):e1006098. PubMed ID: 27341336
[TBL] [Abstract][Full Text] [Related]
57. RT-QuIC Using C-Terminally Truncated α-Synuclein Forms Detects Differences in Seeding Propensity of Different Brain Regions from Synucleinopathies.
Poggiolini I; Erskine D; Vaikath NN; Ponraj J; Mansour S; Morris CM; El-Agnaf OMA
Biomolecules; 2021 May; 11(6):. PubMed ID: 34072869
[TBL] [Abstract][Full Text] [Related]
58. The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson's disease, multiple system atrophy and dementia with Lewy bodies.
Van der Perren A; Gelders G; Fenyi A; Bousset L; Brito F; Peelaerts W; Van den Haute C; Gentleman S; Melki R; Baekelandt V
Acta Neuropathol; 2020 Jun; 139(6):977-1000. PubMed ID: 32356200
[TBL] [Abstract][Full Text] [Related]
59. Trehalose does not improve neuronal survival on exposure to alpha-synuclein pre-formed fibrils.
Redmann M; Wani WY; Volpicelli-Daley L; Darley-Usmar V; Zhang J
Redox Biol; 2017 Apr; 11():429-437. PubMed ID: 28068606
[TBL] [Abstract][Full Text] [Related]
60. α-Synuclein triggers cofilin pathology and dendritic spine impairment via a PrP
Oliveira da Silva MI; Santejo M; Babcock IW; Magalhães A; Minamide LS; Won SJ; Castillo E; Gerhardt E; Fahlbusch C; Swanson RA; Outeiro TF; Taipa R; Ruff M; Bamburg JR; Liz MA
Cell Death Dis; 2024 Apr; 15(4):264. PubMed ID: 38615035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
